Viewing Study NCT06562192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-02-02 @ 9:10 AM
Study NCT ID: NCT06562192
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2024-08-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma View
None Non-small Cell Lung Cancer View
None HR+/HER2- Ductal and Lobular Breast Cancer View
None Triple Negative Breast Cancer View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pancreatic ductal adenocarcinoma View
None non-small cell lung cancer View
None breast cancer View
None colorectal cancer View
None radioligand therapy (RLT) View
None [177Lu]Lu-NNS309 View
None [68Ga]Ga-NNS309 View